Chlorhexidine mouthwash reduces the salivary viral load of SARS-CoV-2: A randomized clinical trial
- PMID: 34837305
- DOI: 10.1111/odi.14086
Chlorhexidine mouthwash reduces the salivary viral load of SARS-CoV-2: A randomized clinical trial
Abstract
Objectives: This study aimed to evaluate the effect of 0.12% chlorhexidine gluconate on the salivary load of SARS-CoV-2.
Materials and methods: A randomized, double-blind, placebo-controlled trial was performed on 100 participants positive for SARS-CoV-2. In the test group (n = 50), volunteers gargled with a mouthwash containing 15 ml of 0.12% chlorhexidine gluconate for 1 min, while the control group (n = 50) used a placebo. Saliva samples were obtained before (baseline) and 5 and 60 min after using the solutions. Real-time reverse transcription polymerase chain reaction assays (qRT-PCR) were carried out and the cycle threshold (Ct) was computed. The chi-square test and t-test were used for group comparison (p ≤ 0.05).
Results: The differences in Ct values between the 5-min evaluation and baseline (test group: 2.19 ± 4.30; control: -0.40 ± 3.87, p = 0.002) and between 60 min and baseline (test group: 2.45 ± 3.88; control: 0.76 ± 4.41, p = 0.05) were significantly greater in the test group, revealing a reduction of viral load. Furthermore, there was a reduction in the load of SARS-CoV-2 in 72% of the volunteers using chlorhexidine versus 30% in the control group (p = 0.001).
Conclusions: Chlorhexidine gluconate (0.12%) was effective in reducing salivary SARS-CoV-2 load for at least 60 min.
Keywords: COVID-19; clinical trial; infection control; mouthwash; pandemic; viral load.
© 2021 Wiley Periodicals LLC.
References
REFERENCES
-
- Addy, M., Jenkins, S., & Newcombe, R. (1991). The effect of some chlorhexidine-containing mouthrinses on salivary bacterial counts. Journal of Clinical Periodontology, 18(2), 90-93. https://doi.org/10.1111/j.1600-051x.1991.tb01694.x
-
- Bidra, A. S., Pelletier, J. S., Westover, J. B., Frank, S., Brown, S. M., & Tessema, B. (2020). Comparison of in vitro inactivation of SARS CoV-2 with hydrogen peroxide and povidone-iodine oral antiseptic rinses. Journal of Prosthodontics: Official Journal of the American College of Prosthodontists, 29(7), 599-603. https://doi.org/10.1111/jopr.13220
-
- Blumenthal, D., Causino, N., Chang, Y. C., Culpepper, L., Marder, W., Saglam, D., Stafford, R., & Starfield, B. (1999). The duration of ambulatory visits to physicians. The Journal of Family Practice, 48(4), 264-271.
-
- Burton, M. J., Clarkson, J. E., Goulao, B., Glenny, A.-M., McBain, A. J., Schilder, A. G. M., Webster, K. E., & Worthington, H. V. (2020). Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them. The Cochrane Database of Systematic Reviews, 9(9), CD013627. https://doi.org/10.1002/14651858.CD013627.pub2
-
- Centers for Disease Control and Prevention - CDC. (2020). Guidance for dental settings: interim infection prevention and control guidance for dental settings during the coronavirus disease 2019 (COVID-19) pandemic; [Accessed 2021 Jan 02]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/dental-settings.html
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
